Heinrichs Bert
Institut für Wissenschaft und Ethik, Universität Bonn, Bonner Talweg 57, D-53113 Bonn, Germany.
Med Health Care Philos. 2005;8(1):29-37. doi: 10.1007/s11019-005-0101-x.
Recent advances in genomic research have led to the development of new diagnostic tools, including tests which make it possible to predict the future occurrence of monogenetic diseases (e.g. Chorea Huntington) or to determine increased susceptibilities to the future development of more complex diseases (e.g. breast cancer). The use of such tests raises a number of ethical, legal and social issues which are usually discussed in terms of rights. However, in the context of predictive genetic tests a key question arises which lies beyond the concept of rights, namely, What should we want to know about our future? In the following I shall discuss this question against the background of Kant's Doctrine of Virtue. It will be demonstrated that the system of duties of virtue that Kant elaborates in the second part of his Metaphysics of Morals offers a theoretical framework for addressing the question of a proper scope of future knowledge as provided by genetic tests. This approach can serve as a source of moral guidance complementary to a justice perspective. It does, however, not rest on the-rather problematic--claim to be able to define what the "good life" is.
基因组研究的最新进展催生了新的诊断工具,包括能够预测单基因疾病(如亨廷顿舞蹈症)未来发病情况或确定患更复杂疾病(如乳腺癌)可能性增加的检测方法。此类检测方法的使用引发了诸多伦理、法律和社会问题,这些问题通常从权利角度进行讨论。然而,在预测性基因检测的背景下,出现了一个关键问题,该问题超出了权利概念,即我们想了解自己未来的哪些情况?接下来,我将在康德的德性学说背景下探讨这个问题。将证明,康德在其《道德形而上学》第二部分阐述的德性义务体系为解决基因检测所提供的未来知识的适当范围问题提供了一个理论框架。这种方法可作为一种道德指导来源,补充正义视角。不过,它并不依赖于那种颇具问题的、声称能够界定“美好生活”是什么的主张。